GLYCOBAL ENFANT
GLYCOBAL ENFANT
Discontinued
DIN Number
00146056
Drug Class
Human
Market Date
Dec 31, 1951
Company
HC
lab nadeau ltée, division of technilab inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00146056
AIG Number0808159001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A11EX VITAMIN B-COMPLEX, OTHER COMBINATIONS
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification88:28.01*
Health Canada Classification
ACTIVE INGREDIENTS (8)
CALCIUM GLYCEROPHOSPHATEActive
Strength: 7.5 MG / ML
Monograph: CALCIUM GLYCEROPHOSPHATE
GLYCEROPHOSPHATE POTASSIUMActive
Strength: 6 MG / ML
Monograph: GLYCEROPHOSPHATE POTASSIUM
MANGANESE GLYCEROPHOSPHATEActive
Strength: 2 MG / ML
Monograph: MANGANESE GLYCEROPHOSPHATE
NICOTINAMIDEActive
Strength: .93 MG / ML
Monograph: NICOTINAMIDE
SODIUM GLYCEROPHOSPHATEActive
Strength: 10 MG / ML
Monograph: SODIUM GLYCEROPHOSPHATE
VITAMIN B1Active
Strength: .25 MG / ML
Monograph: VITAMIN B1
VITAMIN B2Active
Strength: .12 MG / ML
Monograph: VITAMIN B2
VITAMIN B6Active
Strength: .1 MG / ML
Monograph: VITAMIN B6